EP3370770 - Bibliographic data

FORMULATIONS SOUS-CUTANÉE D'ANTICORPS ANTI-CD38 ET LEURS UTILISATIONS

Last update 18/07/2025
Legal status Brevet EP révoqué
Origin Euro-PCT

(73) Holder

JANSSEN BIOTECH, INC.

800/850 Ridgeview Drive
19044
s
HORSHAM, PA
États-Unis d'Amérique
(72) Inventors

Richard JANSSON

3041 Ursulas Way
Doylestown, Pennsylvania 18902
États-Unis d'Amérique

Vineet KUMAR

1400 McKean Raod
Spring House, Pennsylvania 19477
États-Unis d'Amérique
(74) Agent

Mail recipient

Carpmaels & Ransford LLP

One Southampton Row
London WC1B 5HA
Royaume-Uni

(21) Request number EP16862791.7
(22) Request date 01/11/2016

(11) Publication number EP3370770
Publication date 20/01/2021

(54) Title of the invention FORMULATIONS SOUS-CUTANÉE D'ANTICORPS ANTI-CD38 ET LEURS UTILISATIONS
(51) International classification A61K 39/395A61K 31/4439A61K 31/198A61K 31/573A61K 31/69C07K 16/28A61K 9/10A61K 47/12A61K 47/20A61K 47/22A61P 35/00
International classification (before reform) None

Claimed priority

(31) Number: 201562250016 P
(32) Date: 03/11/2015
(33) Country: US

Initial application None
Divisional application EP20215879.6 /EP3827845 None

Expected annuity Annuity: 10 - Amount: 195 € - Due date 01/12/2025
Last annuity Annuity: 9 - Payment date 29/10/2024

Publication None
History

Publication de la délivrance du brevet européen - Legal date 20/01/2021


Modification du mandataire OEB du brevet européen - Legal date 13/08/2021


Révocation du brevet européen - Legal date 22/01/2025